General
Preferred name
FLAVOXATE
Synonyms
FLAVOXATE HYDROCHLORIDE ()
Flavoxato ()
DW61 ()
Rec-7-0040 ()
Flavoxate HCl ()
NSC-114649 ()
Flavoxate (hydrochloride) ()
Flavoxate ()
DW-61 ()
Urispas 200 ()
Urispas ()
Bladuril ()
Flavoxate-d5 ()
P&D ID
PD009777
CAS
3717-88-2
15301-69-6
2748541-85-5
Tags
available
drug
Approved by
FDA
First approval
1970
Drug indication
Nocturia
Dysuria
Urgency
Relaxant (smooth muscle)
Suprapubic pain
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Marketed formulations may contain flavoxate hydrochloride (PubChem CID 441345).
(GtoPdb)
DESCRIPTION
Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct action on the smooth muscle rather than by antagonizing muscarinic receptors.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
22
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
58
Molecular Weight
391.18
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
3
cLogP
4.41
TPSA
59.75
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.6
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Neuroscience
GPCR/G protein
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Neuronal Signaling
Target
mAChR
CHRM1, CHRM2
Calcium Channel
Phosphodiesterase (PDE)
AChR
Indication
urinary incontinence, interstitial cystitis (IC), urethritis, prostatitis
MOA
acetylcholine receptor antagonist
Therapeutic Class
Parasympatholytics
Source data